ReviewBreast (Edinburgh, Scotland)2026

Focusing on toxicity management: Challenges and strategies for HER2-targeted antibody-drug conjugates in breast cancer.

Xiaoyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.